{
  "name" : "dacemirror.sci-hub.se_journal-article_c67e49ddd6a745a62df5882e4f89e1b2_li2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Nanotransducers for Near‐Infrared Photoregulation in Biomedicine",
    "authors" : [ "Jingchao Li", "Hongwei Duan", "Kanyi Pu" ],
    "emails" : [ "kypu@ntu.edu.sg" ],
    "sections" : [ {
      "heading" : null,
      "text" : "PROGRESS REPORT\n1901607 (1 of 18) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.advmat.de\nNanotransducers for Near-Infrared Photoregulation in Biomedicine\nJingchao Li, Hongwei Duan, and Kanyi Pu*\nDr. J. Li, Prof. H. Duan, Prof. K. Pu School of Chemical and Biomedical Engineering Nanyang Technological University Singapore 637457, Singapore E-mail: kypu@ntu.edu.sg\nThe ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/adma.201901607.\nDOI: 10.1002/adma.201901607\nup magnetic equipment;[36] ultrasound has poor tissue targeting and may lead to metastatic disseminations owing to the enhanced vessel permeability;[37] heating and mechanical forces are poorly controllable both temporally and spatially;[38,39] and electrical stimulation is invasive and similarly has poor spatial selectivity.[40] Thereby, the limitations of these external stimuli partially hamper their biomedical applications.\nOne emerging alternative to regulation of biological events is photoregulation, a process in which light is utilized as an external stimulus.[41] Because light has the intrinsic advantages of noninvasiveness, high spatiotemporal resolution, and easy controllability over intensity and wavelength,[42] photoregulation holds promise for an abundance of biomedical applications.[43–45] In addition to photothermal therapy (PTT)[46–48] and photodynamic therapy (PDT)[49–51] with the intention of\nkilling disease cells, light-based applications include photothermal opening of ion channels,[52] photostimulation of lightsensitive proteins,[53–55] photoactivated uncaging of biomolecules,[56–58] photo-crosslinking of tissues,[59] and photocontrolled delivery of cargos.[60–62] However, photoregulation techniques often encounter certain predicaments that compromise their potential applications.[41,63] This mainly results from the widespread use of ultraviolet (UV) or visible light in photoregulation, because the majority of current light-sensitive moieties are only responsive to the light sources at these wavelengths.[63,64] UV and visible light have very shallow tissue penetration depth due to their high absorption and scattering in living tissues.[65] In addition, UV light with high energy per photon has a high probability to damage biomolecules (such as nucleic acids, proteins, and lipids), potentially leading to phototoxicity.[66] To address these issues, the replacement of UV and visible light with a near-infrared (NIR) light source (700–1000 nm) that has lower tissue absorption, less photon scattering, and deeper tissue penetration is highly desired to achieve photoregulation of different biological events.[67]\nMolecular transducers are essential for photoregulation of biological processes because there are few endogenous biomole cules with the ability to respond to NIR light.[68] In this regard, optical nanomaterials have shown their potential to be used as advanced nanotransducers to convert light into various forms of cues to trigger biological events or biomolecular activities. For example, upconversion nanoparticles (UCNPs)\nPhotoregulation, which utilizes light to remotely control biological events, provides a precise way to decipher biology and innovate in medicine; however, its potential is limited by the shallow tissue penetration and/or phototoxicity of ultraviolet (UV)/visible light that are required to match the optical responses of endogenous photosensitive substances. Thereby, biologically friendly near-infrared (NIR) light with improved tissue penetration is desired for photoregulation. Since there are a few endogenous biomolecules absorbing or emitting light in the NIR region, the development of molecular transducers is essential to convert NIR light into the cues for regulation of biological events. In this regard, optical nanomaterials able to convert NIR light into UV/visible light, heat, or free radicals are suitable for this task. Here, the recent developments of optical nanotransducers for NIRlight-mediated photoregulation in medicine are summarized. The emerging applications, including photoregulation of neural activity, gene expression, and visual systems, as well as photochemical tissue bonding, are highlighted, along with the design principles of nanotransducers. Moreover, the current challenges and perspectives in this field are discussed.\nNanotransducers"
    }, {
      "heading" : "1. Introduction",
      "text" : "Remote regulation of biological events has played an important role in biology and medicine since it helps disclose underlying physiological processes in living systems and can potentially lead to novel therapeutic modalities.[1–4] Various external stimuli including magnetic fields,[5–8] ultrasound,[9–11] heating,[12] electric fields,[13–15] and mechanical forces[16–18] have been used as physical cues to control the specific biological processes at the designated sites of living organisms. These stimulation approaches have enabled regulation of biological activities including gene transfection,[19–21] signaling pathways,[22–24] ion channels,[25–27] protein activities,[28] cell functions,[29–31] molecule separation,[32] and tissue regeneration.[33–35] However, a magnetic field requires tens to thousands of seconds to induce adequate strength, probably due to the slow magnetothermal efficiency, and needs complicated operation in setting\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (2 of 18)\ncan convert NIR light into UV and visible light that match the absorption spectrum of light-sensitive moieties or protein-ion channels.[69–71] Organic semiconducting nanoparticles, nanographene oxide, carbon nanotubes, and metal nanoparticles can convert NIR light to generate local heat to allow photothermal stimulation of temperature-sensitive biological behaviors.[72–75] In addition, upon exposure to NIR light, photosensitizer-based nanostructures are capable of producing reactive oxygen species (ROS), a class of highly reactive molecules, to induce biochemical reactions in living subjects.[76–78]\nHere, we summarize the recent development of optical nanotransducers for NIR photoregulation applications, including photoregulation of neurons, gene expression, and visual systems, as well as photochemical tissue bonding (Figure 1). In the following sections, the design principles and optical properties of nanotransducers and corresponding working mechanisms pertaining to NIR-light-mediated photoregulation are discussed, along with representative examples. Lastly, a brief summary is given, along with a discussion of the current challenges and perspectives in this field."
    }, {
      "heading" : "2. Photoregulation of Neurons",
      "text" : "Precise regulation of neural activity is crucial for understanding brain functions and can potentially provide new ways to treat neurological diseases.[36,79,80] Current techniques for neuron regulation include chemical stimulation, ultrasound, electric fields, magnetic fields, local heating, and light irradiation.[15] Among them, light has been widely used in neuroscience to allow neuron activation and neuron inhibition through optogenetics and photothermal stimulation (Table 1)."
    }, {
      "heading" : "2.1. Optogenetics of Neurons",
      "text" : "Optogenetics utilizes light to remotely regulate the light-sensitive microbial ion-channel proteins of genetically engineered neural cells either in vitro or in vivo.[81] Microbial ion-channel proteins such as channelrhodopsin (ChR), halorhodopsin (NpHR), and archaerhodopsin (Arch) can be stimulated upon exposure to a particular wavelength of light, offering high specificity toward light.[81] With the combinational advantages of genetic techniques and light, optogenetics has emerged as an indispensable modulation strategy in neuroscience.[81] However, current optogenetic methods usually rely on visible light, and thus require the implantation of invasive fiberoptic probes into living tissues for signal stimulation.[82–84] To bypass the issue of shallow tissue penetration of existing light-sensitive ion-channel proteins, UCNPs with NIR light absorption but visible light emission have been applied in optogenetics.\nUtilization of UCNP-mediated optogenetics for stimulation of cultured neural cells has been widely reported.[85,86] In a recent study, mouse neuroblastoma/rat dorsal root ganglion (DRG) neuron hybrid ND7/23 cells were genetically engineered to express ChR variants (C1V1 and mVChR1) and were then cultured on a NaYF4:Sc/Yb/Er UCNP-coated coverslip. Upon irradiation with an NIR laser (975 nm), the UCNPs emitted green light, which subsequently activated C1V1 and mVChR1 to generate action potentials in neural cells.[85] In another similar study, NaYF4:Yb/Tm@NaYF4 core–shell UCNPs were embedded into a biocompatible poly(lactic-coglycolic acid) (PLGA) film to form a hybrid scaffold for culture of hippocampal neurons expressing ChR2, a microbial ion channel that responded to blue light.[86] Such a UCNPs/ PLGA hybrid scaffold allowed conversion of 980 nm NIR light to blue luminescence, inducing neuronal activation with an efficiency comparable to that of 470 nm blue light. More importantly, the efficiencies of UCNP-mediated optogenetics can be boosted through increasing the upconversion luminescence of UCNPs. As demonstrated by Han’s group, UCNPs were doped with ytterbium ions (Yb3+) into their shells and conjugated with IR-806 dyes to the surface, yielding dye-sensitized core–active-shell UCNPs. Such nanoparticles showed 8- and 1000-fold enhancements in the upconversion efficiency relative to the counterparts without Yb3+ doping and without IR-806 dye conjugation, respectively.[87] The amplified upconversion property eventually led to a robust NIR-induced activation of hippocampal neurons expressing ReaChR cultured on the polymer films embedded with the dye-sensitized core– active-shell UCNPs.\nJingchao Li received his Ph.D. degree in materials science and engineering from the University of Tsukuba (Japan) in 2017. Then, he worked as a Postdoctoral Research Fellow in Prof. Kanyi Pu’s group in the School of Chemical and Biomedical Engineering (SCBE), Nanyang Technological University (NTU). His current research\nfocuses on the development of advanced optical agents for cancer theranostics and biological photoregulation.\nKanyi Pu received his Ph.D. from the National University of Singapore in 2011, followed by a postdoctoral position at Stanford University School of Medicine. He joined the School of Chemical and Biomedical Engineering (SCBE) at Nanyang Technological University (NTU) as an Associate\nProfessor in 2015. His research lies at the intersection of chemistry, nanotechnology, biophotonics, and medicine, aiming to develop smart molecular probes and advanced imaging technologies to understand, detect, and treat lifethreatening diseases.\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (3 of 18)\nThanks to the enhanced tissue-penetration depth of NIR light, UCNP-mediated optogenetics has been used for stimulation of deep brain neurons in living animals. Incorporation of Tm3+ into Yb3+-doped NaYF4 UCNPs allowed the conversion of 980 nm NIR light to blue emission, which matched the maximum absorption of ChR2 (Figure 2a,b).[88] Blue emission could be recorded in the ventral tegmental area (VTA) of a mouse brain after local injection of UCNPs upon NIR laser irradiation (Figure 2c,d), confirming upconversion emission in the deep brain. Silica-coated UCNPs (termed as NaYF4:Yb/Tm@SiO2 UCNPs) were chosen for in vivo optogenetic activation because of their minimum cytotoxicity (Figure 2e). To test the in vivo utility of UCNP-mediated optogenetics, the VTA of a tyrosine hydroxylase (TH)-driven Cre recombinase (TH-Cre) transgenic mouse was injected with an adeno-associated virus (AAV) encoding ChR2, leading to Cre-dependent expression of ChR2 in dopamine (DA) neurons (Figure 2f). In vivo optogenetic activation of VTA DA neurons was only triggered by NIR light in ChR2-transfected mice with NaYF4:Yb/Tm@SiO2 UCNPs injection, as indicated by the significantly elevated proportion of neural cells expressing c-Fos, a typical biochemical marker for neuronal activation (Figure 2g). In addition, obvious striatal DA transients were observed in the same treated mice (Figure 2h–j), which reflected the phasic spike activity. Similarly, Wang and Shi and co-workers reported the utilization of UCNPs for in vivo optogenetic activation of rat-brain neurons expressing ChR2 and C1V1 by implanting a micro-optrode containing Tm3+- and Er3+-doped UCNPs into the visual cortex of an adult Sprague–Dawley (SD) rat, respectively.[89] Increased spiking activity and strong expression of c-Fos were observed for neurons after NIR light stimulation.\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (5 of 18)\nIn addition to neuronal activation, UCNP-mediated optogenetics has permitted inhibition of neurons by stimulating green light–sensitive ion-channel proteins, such as NpHR and Arch, two commonly used opsin proteins for neuronal inhibition.[90] With co-doping of Er3+ and Yb3+ into the NaYF4 host lattice, emission of silica-coated UCNPs (termed as NaYF4:Yb/Er@ SiO2 UCNPs) was tuned to ≈540 nm, which matched the maximum absorption of Arch (Figure 2k).[88] After injection of these UCNPs and NIR laser exposure, a mouse with the expression of Arch in the excitatory neurons had an obviously reduced level of\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (6 of 18)\nc-Fos expression in the granule cells of the dentate gyrus (DS) (Figure 2l,m), indicating effective inhibition of hippocampal neurons. In another study, NaYF4@NaYF4:Yb/Er@NaYF4 core– shell–core-structured UCNPs with almost threefold enhanced upconversion luminescence at 540–570 nm relative to traditional core–shell counterparts were also developed for optogenetic inhibition of neurons.[91] After implantation of the devices containing these core–shell–core UCNPs into targeted regions deep in the rat brain, the electrical activity of NpHR-expressing neurons was reliably inhibited upon NIR laser illumination at 980 nm and could be immediately restored to a normal level by switching off the NIR light. Such a UCNP-mediated optogenetic inhibition was also reported to suppress the secondary motor cortex in mice and modulate their locomotion behaviors in an open field."
    }, {
      "heading" : "2.2. Photothermal Stimulation",
      "text" : "Although optogenetics has achieved successes in regulating neuronal activity, its requirement of complicated genetic modification of target neural cells partially constrains its broad applications.[92] Direct photothermal stimulation of unmodified neurons is an alternative to precisely regulate neuronal activities. In this case, optical nanomaterials can act as photothermal nanotransducers to convert NIR light stimulation into local mild heat (<43 °C) at the neuronal plasma membrane, and such temperature increments allow temperature-sensitive ion channels to be activated, regulating the activities of neurons.\nOptical nanomaterials with NIR absorption, including carbon nanohorns (CNHs),[93] gold nanorods (AuNRs),[94–96] and liquid–metal nanocapsules,[97] have been shown to be effective in photothermal activation of neurons. Upon interaction with neurons, these optical nanomaterials enabled generation of local mild heat through photothermal conversion under NIR laser irradiation, allowing the activation of temperaturesensitive transient receptor potential cation channel subfamily V member 1 (TRPV1), a typical ion-permeable polymodal channel intrinsically overexpressed on the plasma membrane of neurons.[93] The activation of TRPV1 induced Ca2+ influx of neurons, a vital biological process in neurotransmitter release. However, without a targeting selectivity and specificity, most of these systems can encounter the predicament of poor activation efficiency and potential damage to the cellular membranes.\nTo allow selective and specific photothermal activation of neurons, Pu’s group designed a semiconducting polymer nanobioconjugate (SPNbc) that targeted TRPV1 receptor on neuron surface.[98] A semiconducting polymer (SP1, Figure 3a) was synthesized and transformed into semiconducting polymer nanoparticles (SPN1) via nanocoprecipitation with an amphiphilic polymer, polystyrene-block-poly(acrylic acid) (PS–PAA) (Figure 3b). Owing to the enhanced charge transfer of SP1, the maximum absorption of SPN1 was redshifted by 100 to 766 nm as compared to that of counterpart SPN2 (660 nm), while the control AuNRs had their maximum absorption at 780 nm (Figure 3c). Under 808 nm laser irradiation, SPN1 showed a faster heating capability relative to both SPN2 and AuNRs. SPN1 was conjugated with an anti-TRPV1 antibody to obtain SPN1bc, which allowed effective binding with the TRPV1 ion\nchannels on the surface of ND7/23 neuronal cells (Figure 3d). Such a targeted binding permitted quick diffusion of locally generated heat from SPN1bc to TRPV1, achieving specific activation of TRPV1 ion channels and subsequent intracellular Ca2+ influx (Figure 3e). Real-time monitoring of Ca2+ influx with a fluorescent turn-on indicator (Fluo-8) showed that as soon as the 808 nm NIR laser irradiation initiated, the Fluo-8 fluorescence immediately increased until its plateau at ≈1.5 s for SPN1bc-treated ND7/23 cells (Figure 3f,g), while this was not observed for SPN1bc-treated TRPV1 negative control cells (HeLa cells) and SPN2bc-treated ND7/23 cells. In addition, the TRPV1 Ca2+ channels could be reversibly activated and silenced by switching on/off the NIR laser at an interval of 0.5 s (Figure 3h), demonstrating the capability of simultaneous input–output interrogation of neuronal cells within milliseconds.\nNanomaterial-based photothermal stimulation can also be used to inhibit neuronal activity. For example, Nam’s group showed that photothermal heating mediated by AuNRs attached on the neural plasma membrane inhibited the action potentials and spike rates of hippocampal neurons upon 785 nm NIR laser exposure, and the neuronal activity was completely recovered after removal of the laser source.[99] Such an inhibitory action was reported to be associated with the photothermal stimulation of temperature-sensitive TREK-1 channel, a K+ channel widely expressed throughout the whole brain region including the hippocampus that intrinsically reduced neuronal activity. The same group also showed that this AuNR-mediated photothermal inhibitory technique could be further integrated into conventional neurodevices to allow an effective suppression of the spontaneous firing of hippocampal neurons, and also their signal propagation along neurites evoked by electrical stimulation.[100] Beyond that, gold nanostars (AuNSs) were similarly utilized to optically inhibit neuronal activity even at single-cell level.[101]"
    }, {
      "heading" : "3. Photoregulation of Gene Expression",
      "text" : "Remote regulation of intracellular gene expression provides a precise way to understand the physiological roles of a particular gene and its therapeutic potential.[102–104] Currently, radio waves, gas molecules, magnetic fields, and light irradiation have been used to remotely switch on gene expression.[63,105,106] Of these, NIR light is the most ideal external trigger because it can precisely control transgenic actions at designated locations and times so as to minimize off-target gene expression. NIR-light-mediated regulations of gene expression can mainly be achieved through three different mechanisms: optogenetics, photothermic gene expression, and activation of photocaged transgenic systems (Table 1)."
    }, {
      "heading" : "3.1. Optogenetics of Gene Expression",
      "text" : "In addition to neural activity regulation, optogenetics can be adopted to modulate intracellular gene expression.[107] For instance, an NIR-inducible optogenetic nanoplatform (termed as Opto-CRAC) was constructed to enable remote photoregulation of intracellular Ca2+ influx and Ca2+-dependent gene expression.[107] In this system, target cells were genetically encoded to express ORAI1StrepTag (streptavidin-binding tag inserted\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (7 of 18)\ninto the second extracellular loop of ORAI1 Ca2+ channel) and LOVSoc (stromal interaction molecule 1 cytosolic domain, STIM1-CT fragments inserted with a photoswitch LOV2 domain), while NaYF4:Yb,Tm@NaYF4 UCNPs with a bright blue emission upon 980 nm NIR laser irradiation were conjugated with streptavidin to allow their targeted accumulation onto the plasma membranes (Figure 4a). UCNP-transduced blue light matched the absorption window of LOV2 domains for activation well, leading to the opening of ORAI1 Ca2+ channels. Thus, Ca2+ influx occurred to trigger the gene transcription of Ca2+-dependent master transcriptional regulator NFAT (nuclear factor of activated T cells) and downstream cloned genes of interest, such as luciferase (Figure 4b,c). Interestingly, this optogenetic system was used for activation of dendritic cell (DC)-mediated immunotherapy, wherein NIR light irradiation resulted in a two- to eightfold increment in the expression of major histocompatibility complex-I/II (MHC-I/II), cluster of differentiation 86 (CD86), and CC-chemokine receptor 7 (CCR7) on the surface of the DCs (Figure 4d). After the injection of UCNPsStv in alliance with ovalbumin (OVA)-loaded Opto-CRAC DCs into a B16-OVA murine model of melanoma, an antitumor immune response was elicited upon 980 nm NIR laser irradiation, which significantly suppressed tumor growth and reduced the number of tumor metastasis in the lungs (Figure 4e–g). In another study, the use of UCNP-mediated optogenetics to activate the apoptotic signaling pathway for cancer therapy was reported.[108] Cancer cells were transfected with DNA plasmids to express blue-light-responsive arabidopsis flavoprotein cryptochrome 2 (Cry2), mCherry, and Fas-associated protein with death domain (FADD) on their cytoplasmic membranes, while Fas and Cry2 binding partner (Cib1) on the plasma membranes. Under 980 nm NIR laser irradiation, the UCNPs emitted local blue light to trigger the translocation of Cry2-mCherry-FADD from cytoplasmic membranes to plasma membranes, inducing the Cry2–Cib1 interaction (Figure 4h,i). At the same time, Fas worked together with its adaptor molecule FADD, which activated the apoptotic signaling pathway (Figure 4j). As a result, such an NIR-controlled optogenetic nanosystem was reported to induce a more than sixfold enhanced mortality for cancer cells, and significantly suppress tumor growth in living mice, which was impossible for blue light, owing to its weak penetrability."
    }, {
      "heading" : "3.2. Photothermic Gene Expression",
      "text" : "Since living cells are known to be sensitive to temperature changes in different perspectives, nanomaterial-mediated local photothermal stimulation within the physiological ranges can\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (8 of 18)\nbe utilized to control cell behaviors through regulating intracellular gene transcription.[109,110] For example, Lim and Cho et al. recently reported the photothermic activation of receptor-ligand multivalent interactions to enable dynamic regulation of stem cell differentiation.[110] This was demonstrated through treating human neural stem cells (hNSCs) with single-walled carbon nanotubes (SWCNTs) noncovalently assembled with RGD peptides and thermoresponsive dendrimers. Photothermal heating of these SWCNTs induced the shrinkage of the thermoresponsive dendrimers, owing to their lower critical solution temperature (LCST) behavior, which triggered the surface presentation of RGD peptides to enable their bindings with β1-integrins on the membranes of hNSCs. As such, this RGD-integrin receptor clustering upregulated the gene expression of neuronal biomarkers (Tuj1 and MAP2) and promoted the differentiation of hNSCs into electrophysiologically functional neurons. Mild temperature increments can also facilitate upregulation of some thermosensitive biomolecules in living biological\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (9 of 18)\nsystems, such as heat-shock protein, which allows gene transcription to occur. As reported by Ciofani’s group, photothermal conversion of gold nanoshells (AuNSHs) under NIR laser irradiation at 808 nm was exploited to remotely activate striated muscle cells through upregulating-related gene expression.[111] In their study, the chronic remote photothermal stimulation wirelessly upregulated the mRNA transcription of genes encoding heat-shock proteins and sirtuin 1 (SIRT1), a protein which in turn induced mitochondrial biogenesis.\nIn addition to endogenous genes, nanomaterial-mediated local photothermal stimulation can upregulate the expression of various exogenous genes of interest inserted downstream of the heat-shock promoters (HSPs), providing a useful tool to treat inherited genetic diseases and cancers. In this regard, Pu’s group reported the development of an NIR-absorbing dendronized semiconducting polymer (DSP) and utilized it as a photothermal nanocarrier and intracellular nanotransducer for remote photoregulation of gene expression in living cells and animals.[112] Such a DSP comprised a hydrophobic semiconducting polymer (SP2) backbone, cationic third-generation polyamidoamine (PAMAM3) side chains, and neural PEG blocks, in which these components served as the NIR photothermal nanotransducer, gene vector, and water-solubility enhancer, respectively (Figure 5a). To achieve efficient delivery of genes, plasmids with the incorporation of genes of interest cloned downstream of a heat-inducible promoter (HSP70) were complexed with DSP, affording nanocomplexes. After cellular internalization, plasmids were released from the nanocomplexes and entered into cellular nucleus, while DSP retained in the cytoplasm. Upon laser irradiation at 808 nm, DSP generated local mild heat, stimulating the HSP70 promoter to activate transcription of downstream genes (Figure 5b). Using luciferase plasmid (pSV40-Luc) as the model gene, such DSP-mediated photothermal activation rapidly triggered 25- and 4.5-fold increments in the expression of luciferase in living cells and mice, respectively (Figure 5c–f). Another two similar studies also presented the use of CNHs and SPNs for photothermic activation of gene expression.[113,114] Modification of nanomaterials with Tat peptide (RKKRRQRRRC) allowed their location on the surface of cell membranes, which could improve the specificity and efficiency for photoactivated gene expression. However, all these nanomaterials were simply utilized as the transducers for heating, and gene-delivery systems were required to be conducted in a separate step.\nUsing a tumor suppressor gene (e.g., p53) as the target gene, Chang and co-workers demonstrated that nanomaterialmediated photothermic activation of gene transcription could be adopted for gene therapy of tumors.[115] In their work, the therapeutic plasmid DNA (pDNA), designed to contain HSP70 as the promoter, green fluorescent protein (GFP) as the reporter gene, and tumor suppressor p53 gene as the encoded target gene, was loaded into polyethyleneimine-modified prussian blue nanocubes (PB@PEI NCs). Owing to the excellent photothermal conversion property of PB NCs, mild NIR laser irradiation at 808 nm increased the temperature to ≈41 °C, which stimulated the HSP70 promoter to activate the expression of p53 protein and led to the apoptosis of cancer cells. Such a p53-dependent gene therapy synergized with PTT by adjusting the level of the photothermal effect at temperature from ≈41 to ≈50 °C, achieving significant cell damage and tumor-growth inhibition.\nThe nanomaterial-mediated local photothermal effect has also been utilized as a stimulus for the control of Ca2+-dependent gene expression. In this case, following NIR laser irradiation, the increase in local temperature opens the TRPV1 ion channels or triggers cell membrane permeabilization to allow Ca2+ influx; the increased cytosolic Ca2+ activates Ca2+-responsive gene elements in the Ca2+-dependent signaling pathway, which induces downstream expression of genes of interest.[116] This photothermal genic switching strategy was recently adopted by Tang’s group to locally and temporally impede the progression of atherosclerosis.[117] In their work, copper sulfide (CuS) NPs conjugated with anti-TRPV1 antibodies were used as remote transducers to specifically bind to TRPV1 on the plasma membrane of vascular smooth muscle cells (VSMCs), allowing a local temperature increase upon 980 nm NIR laser irradiation. This local heating triggered opening of TRPV1 ion channels and influx of Ca2+, subsequently initiated the activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK)-associated autophagy and upregulation of adenosine triphosphate (ATP)-binding cassette transporter A1 (ABCA1) gene expression, and eventually resulted in enhanced cholesterol efflux and decreased lipid accumulation and foam-cell formation in the oxidized low-density lipoprotein (oxLDL)-treated VSMCs (Figure 5g,h). More importantly, CuS-anti-TRPV1 was used to target the aortic arch after intravenous administration, affording a desirable therapeutic efficiency in obviously reducing lipid storage and atherosclerotic lesions in the aortic arch of plaquebearing apolipoprotein E knockout (ApoE−/−) mice (Figure 5i).\nNanomaterial-mediated photothermal conversions can enable the controlled delivery of bioactive modulators from temperature-responsive carriers, which makes remote manipulation of gene expression and intracellular signaling pathways feasible. For instance, Tortiglione and co-workers constructed a temperature-responsive polyelectrolyte multilayer nano capsule containing Au nanoparticles as the photothermal agents to mediate capsule-wall opening upon NIR laser irradiation, allowing the local delivery of alkaline phosphatase (ALP) in Hydra to trigger the activation of the Wnt/β-catenin molecular signaling pathway.[118] In another study, Chen and co-workers developed a temperature-responsive protein-delivery system by conjugating a protein complex of growth factor β (TGF-β) with SWCNTs through a homodimer of the latency-associated peptide (LAP), in which TGF-β was inactive.[74] Upon NIR laser irradiation at 980 nm, TGF-β was released from LAP via the photothermal effect of the SWCNTs and became active; the activated TGF-β bound with TGF-β receptors on the cell surfaces, consequently activating intracellular small mothers against decapentaplegic (SMAD) protein complexes to modulate relevant gene transcription. Such a photothermally mediated TGF-β signal transduction activation was able to activate the epithelial–mesenchymal transition (EMT) of normal murine mammary gland cells and protein expression in living mice."
    }, {
      "heading" : "3.3. Activation of Photocaged Transgenic Systems",
      "text" : "Controlling the activity of exogenous nucleic acids and other biomolecules in specific cells by light has been another promising means to regulate transgenic systems and cellular behaviors.\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (10 of 18)\nPhotoregulation of nucleic acids has been realized in a way that involves its caging using a photolabile moiety and then uncaging and release at the desired sites and times upon irradiation of light at a specific wavelength.[119,120] This method was recently reported by Zhang and co-workers to control gene expression and knockdown.[121] Plasmid DNA and siRNA were caged with UV-lightsensitive 1-(4,5-dimethoxy-2-nitrophenyl)diazoethane (DMNPE) to block their activity and then loaded into mesoporous-silica-coated NaYF4:Yb,Er UCNPs. Upon NIR laser irradiation at 980 nm, the UCNPs were able to emitted UV light locally to restore the activity of the nucleic acids, resulting in the expression and knockdown of GFP in cells and animal models. Similarly, Bian and co-workers encapsulated DMNPE/siRNA into mesoporous silica-coated UCNPs and conjugated them with an enzyme-cleavable imaging\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (11 of 18)\nunit for remote regulation of stem cell differentiation as well as simultaneous monitoring of differentiation processes.[122]\nIn addition to photocaged nucleic acids, Zhang’s group recently reported the utilization of photomorpholinos for NIR-light-triggered regulation of both gene expression and gene knockdown.[123–125] Photomorpholinos are nonfunctional morpholinos incorporated with photocleavable moieties, which become active upon UV irradiation. For instance, mesoporous-silica-coated NaYF4:Yb,Tm@NaYF4:Yb,Er UCNPs that emitted both UV and visible light were synthesized and coloaded with an antisignal transducer and activator of transcription 3 (STAT-3) photomorpholino and an endosome localizing photosensitizer mesotetraphenylporphyrin (TPPS2a). The UCNP-emitted UV light activated the photomorpholino to participate in RNA interference, while the visible light activated TPPS2a to disrupt endosomal membranes and enhance photomorpholino delivery. As a result, these UCNPs delivered into B16F0 cells, and tumor models in living mice were reported to enhance the endosomal escape and knockdown the expression of STAT-3 upon NIR laser irradiation.\nBy taking advantage of the light-responsive property of photocleavable caging, controlled release of genic modulators in cells of interest has been demonstrated to allow remote regulation of gene expression and cellular functions.[126,127] In an interesting study, Bian and co-workers developed a UCNP-based carrier with photocleavable uncaging capability for NIR-light-mediated control of intracellular Ca2+ levels to regulate macrophage polarization.[128] Mesoporous-silica-coated UCNPs were loaded with either 1-(4,5-dimethoxy-2-nitrophenyl)-1,2-diaminoethane-N,N,N′,N′-\ntetraacetic acid (caged Ca2+, DMNP–EDTA–Ca2+ complex), which served as the Ca2+ supplier, or 1,2-bis(2-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM), which served as a Ca2+ chelator, which were further conjugated with RGD-peptide-bearing molecular caps via a UV photolabile linker as the photosensitive gating structure. NIR laser irradiation at 980 nm enabled on-demand release of Ca2+ regulators via cleavage of the photosensitive caps and modulation of intracellular Ca2+ levels, which regulated relevant gene expression, thereby promoting M1 or M2 polarization of macrophages.\nBian’s group also loaded a chondro-inductive kartogenin (KGN) into these photocleavable nanocarriers to demonstrate their applications in tissue engineering.[129] RGD–integrin bindings facilitated internalization of these UCNP-based nanocomplexes into bone marrow–derived human mesenchymal stem cells (hMSCs), wherein this NIR-to-UV light conversion triggered an intracellular photo-uncaging and release of cargo molecules to remotely control the intracellular Ca2+ levels and regulate stem cell differentiation (Figure 6a). Importantly, in vivo remote regulation of differentiation of hMSCs could be achieved by encapsulating these nanocomplexes within hyaluronic acid hydrogels for subcutaneous implantation. Such an NIR-triggered delivery of KGN alone activated the differentiation of hMSCs into hypertrophic chondrocytes (Figure 6b), whereas NIR-triggered co-delivery of Ca2+ chelators and KGN induced the differentiation of hMSCs to classic chondrocytes by inhibiting their hypertrophy (Figure 6c). Conversely, NIR-triggered co-delivery of Ca2+ suppliers and KGN promoted the differentiation of hMSCs into osteoblasts (Figure 6d).\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (12 of 18)"
    }, {
      "heading" : "4. Photoregulation of Visual Systems",
      "text" : "Vision is an important sensory modality for mammals.[130] The degeneration of photoreceptors in the retina often leads to blindness.[131] It has been shown that the use of optical materials can activate the reinstatement of vision. As an example, Benfenati and co-workers recently fabricated a completely organic prosthesis composed of a silk substrate covered with photoactive layers of semiconducting polymers and implanted it into the subretinal space of dystrophic Royal College of Surgeons (RCS) rats, a widely recognized model of retinitis pigmentosa.[131] This was reported to allow a significant recovery of light sensitivity and visual acuity that persisted up to 6–10 months after implantation.\nIn addition to visual reinstatement, optical nanotransducers can activate photoreceptors to allow mammals to even see NIR light (Table 1). This idea was recently validated by Xue and coworkers via injecting photoreceptor-binding UCNPs (pbUCNPs) into the subretinal space in the eyes of mice.[132] To match the most sensitive visible light of eyes at an electromagnetic wavelength of ≈550 nm, NaYF4:Yb,Er@NaYF4 core–shell-structured UCNPs with an emission peak at 535 nm upon 980 nm NIR light irradiation were conjugated with concanavalin A protein (ConA) to generate pbUCNPs (Figure 7a). Since ConA could bind to sugar residues and derivatives of the photoreceptor outer segment through forming glyosidic bonds, such pbUCNPs had the capability of anchoring and binding to the photoreceptors in the mouse retina (Figure 7b). The rods of pbUCNP-injected mice under 980 nm NIR light irradiation had similar photocurrents to those for the pbUCNP-injected and noninjected mice under normal visible light (535 nm) irradiation, while the rods from noninjected mice under 980 nm NIR light irradiation showed no response (Figure 7c), suggesting NIR-light-mediated activation of photoreceptors. As such, pbUCNP-treated mice could consciously perceive NIR light as witnessed by the observation that they exhibited a significant preference for the dark box in the light–dark box experiments, while the nontreated control mice could not distinguish between the 980 nm NIR light-illuminated and dark boxes (Figure 7d). In Y-shaped water maze behavioral experiments, it was further confirmed that pbUCNP-treated mice had acquired NIR-light-imaging visual ability by recording their visually evoked potential (VEP) and obtained NIR-light-pattern vision. After training with 980 nm light gratings, the pbUCNP-injected mice could distinguish the two different orientations (vertical and horizontal) of NIR light gratings, whereas the noninjected control mice made such choices in a random manner (Figure 7e–h). The mice trained with visible-light gratings in the parallel control groups were also able to find the associated platform regardless of the injection of pbUCNPs. Moreover, the implantation of pbUCNPs was reported to not cause retinal degeneration, inflammation, cell apoptosis, or any other long-term side effects."
    }, {
      "heading" : "5. Photochemical Tissue Bonding",
      "text" : "Photochemical tissue bonding (PTB), a novel noninvasive technique that combines light with photosensitizers for wound tissue repair, has been regarded as a potential alternative to\ntraditional stapling and suturing.[133] PTB relies on the photoactivation of photosensitizers to release reactive species, creating effective crosslinking between apposed tissue surfaces. Current PTB is often performed employing Rose Bengal (RB) as the photosensitizer in damaged tissue and subsequently irradiating in situ with green light, which has been used to repair a variety of tissues including skin, blood vessels, vocal cords, cornea, and peripheral nerves.[134] Nevertheless, the shallow tissue penetration depth of green light is a serious limitation, making it challenging for clinical applications.\nTo overcome the penetrating limitation of the exciting light, Hahn and co-workers developed a conjugate nanocomplex containing poly(allylamine) (PAAm)-modified UCNPs, hyaluronate (HA), and RB (termed as UCNP/PAAm/HA-RB) and used it for deep-tissue PTB under NIR light illumination (Figure 8a).[135] In such nanocomplexes, the outer HA layer allowed them to be transdermally delivered into a deep and wide area from the boundary of incision, because HA could hydrate the skin barrier and penetrate through the skin, as well as target the highly expressed HA receptors in skin tissues. Upon 980 nm light irradiation, UCNP cores converted the NIR light into green light to activate the RB, resulting in an accelerated collagen crosslinking in porcine skin (Figure 8b,c). Additionally, such a UCNP-mediated PTB technique with NIR light irradiation afforded 2.1- and 1.6-fold faster tissue bonding of an incision on the dorsal skin of mice as compared to the HA-RB conjugate group with green light irradiation and conventional suturing, respectively (Figure 8d,e)."
    }, {
      "heading" : "6. Conclusions and Outlook",
      "text" : "Biological photoregulation represents a promising remotecontrol approach to potentially enable many biomedical applications, ranging from regulation of cellular function to cancer therapy and even tissue engineering. Compared with traditional technologies relying on UV/vis light, NIR photoregulation has lower toxicity and deeper tissue penetration, and thereby is more suitable for in vivo applications. Since few endogenous biomolecules have been found to absorb or emit NIR light, exogenous transducers are generally required for effective NIR photoregulation. NIR nanomaterials can be modified to have desired interactions with different biological systems including nucleic acids, proteins, membranes, organelles, and whole cells meanwhile to allow the well-controlled photoenergy transduction,[136] making them competent as key nanotransducers in the processes of photoregulation.\nHerein, we have summarized the recent development of nanotransducers for NIR-light-mediated photoregulation. For instance, UCNPs can convert NIR light to UV/visible light to stimulate light-sensitive proteins, photocaged moieties, and retinal photoreceptors, enabling remote activation of neuronal activity, gene transcription, signaling pathways, stem cell differentiation, immune response, and ocular visual systems. Photosensitizer-based nanoparticles are capable of generating free radicals upon NIR light irradiation, which activates collagen crosslinking and tissue bonding. Other optical nanomaterials, such as SPNs, liquid–metal nanocapsules, SWCNTs, AuNRs, and AuNSs exert photothermal heating capabilities, resulting in\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (13 of 18)\nAdv. Mater. 2019, 1901607\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (14 of 18)\nAdv. Mater. 2019, 1901607\nthe regulation of ion channels, gene expression, signal transduction, and cell differentiation.\nApplication of optical nanomaterials as nanotransducers for NIR photoregulation of biological events is only at the proof-ofconcept stage, and it is required that several critical concerns are addressed. First, because nanomaterials are known to accumulate in tissues after systemic administration and excrete slowly out of the body, their long-term safety and toxicity profiles still remain questionable.[137–141] Some efforts have been made to mitigate this critical issue.[142–144] For example, the particle size of nanomaterials can be reduced to the level below the renal filtration threshold (≈5 nm), which guarantees the rapid clearance via urine excretion.[145,146] Even though these ultrasmall nanomaterials are nonbiodegradable, they can undergo fast metabolism to attenuate their accumulation into tissues and reduce the toxicity risk. Alternatively, rational designs of nanomaterials to endow their biodegradability are highly desired.[147–150] Shi’s group has reported the biodegradation of inorganic silica nanomaterials through hybridizing them with biodegradable organic disulfide bonds or doping them with metal manganese ions.[151–153] We and others have also shown that molecular integration of vinylene bond,[154] thiophene moiety,[155] imine bond,[156] or imidazole unit[157] into organic nanoparticles (SPNs) is able to facilitate their in vivo biodegradation and thus clearance.\nSecond, the tissue penetration depth of NIR light is still limited, although it has shown to be improved as compared\nto that of UV and visible light. Thus, NIR photoregulation is more suitable for cultured cells and superficial tissues in living subjects.[158] Currently, several emerging options have provided leverage to offset this constraint. For example, modification of light-delivery methods should be a solution, and this was presented by Kobayashi and co-workers, who combined external and interstitial NIR light exposure to improve the light delivery into deep-seated tissues.[159] In addition, nanomaterials with optical absorption in the second NIR window (1000–1800 nm) have been developed with further improved tissue penetration depth.[160–163]\nThird, the photon conversion efficiencies of nanomaterials still need to be improved to promote effective photoregulation in biomedicine. A recent study discovered that attachments of NIR dyes onto the surface of lanthanide-doped UCNPs afforded a ≈33 000-fold increase in their NIR-to-visible upconversion efficiency over bare UCNPs.[164] Some other methods, such as molecule acceptor doping,[165] light-harvesting unit integration,[166] and polydopamine coating[167] have shown great potential in increasing the photothermal conversion efficiencies of nanomaterials. In addition, the ROS production used for photochemical tissue bonding could be amplified through incorporation of photosensitizers into optical nanomaterials or molecular engineering of photosensitizers.[168–171]\nIn addition to neural activity, gene transcription, ocular visual systems, and tissue binding as exemplified above,\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (15 of 18)\nAdv. Mater. 2019, 1901607\nnanomaterial-mediated photoregulation is expected to exert specific roles in other fields of biomedicine. In view of the existence of thermosensitive and photosensitive enzymes in living systems, photoregulation of enzymatic activities could provide a powerful means to control intracellular biochemical reactions and signal transduction.[67,72,172–174] The emergence of photodegradable and photoswitched compounds can lead to photoactivation of prodrugs, which could facilitate precise medicine with high efficacies and minimum side effects.[175–178] Moreover, the photodynamic feature of optical nanomaterials provides the probabilities for photoactivation of photoimmunotherapy (PIT), which can selectively induce tumor destruction and reduce tumor recurrence with minimized damage to normal tissues.[179–181]"
    }, {
      "heading" : "Acknowledgements",
      "text" : "K.P. thanks Nanyang Technological University (Start-Up grant: M4081627) and Singapore Ministry of Education (Academic Research Fund Tier 1: RG133/15 M4011559 and Academic Research Fund Tier 2 MOE2016-T2-1-098) for the financial support.\nConflict of Interest The authors declare no conflict of interest.\nKeywords biomedicine, nanoparticles, nanotransducers, near-infrared light, photoregulation\nReceived: March 13, 2019 Revised: April 5, 2019\nPublished online:\n[1] N. Sonenberg, A. G. Hinnebusch, Cell 2009, 136, 731. [2] X. Ai, L. Lyu, Y. Zhang, Y. Tang, J. Mu, F. Liu, Y. Zhou, Z. Zuo,\nG. Liu, B. Xing, Angew. Chem., Int. Ed. 2017, 56, 3031. [3] S. A. Stanley, J. Sauer, R. S. Kane, J. S. Dordick, J. M. Friedman,\nNat. Med. 2015, 21, 92. [4] E. Miyako, S. A. Chechetka, M. Doi, E. Yuba, K. Kono, Angew.\nChem., Int. Ed. 2015, 54, 9903. [5] C. Monzel, C. Vicario, J. Piehler, M. Coppey, M. Dahan, Chem. Sci.\n2017, 8, 7330. [6] M. Rotherham, J. R. Henstock, O. Qutachi, A. J. El Haj, Nanomedi-\ncine 2018, 14, 173. [7] M. A. Wheeler, C. J. Smith, M. Ottolini, B. S. Barker, A. M. Purohit,\nR. M. Grippo, R. P. Gaykema, A. J. Spano, M. P. Beenhakker, S. Kucenas, Nat. Neurosci. 2016, 19, 756. [8] H. Kang, D. S. H. Wong, X. Yan, H. J. Jung, S. Kim, S. Lin, K. Wei, G. Li, V. P. Dravid, L. Bian, ACS Nano 2017, 11, 9636. [9] A. Marino, M. Battaglini, D. De Pasquale, A. Degl’Innocenti, G. Ciofani, Sci. Rep. 2018, 8, 6257. [10] J. H. Cui, K. Park, S. R. Park, B.-H. Min, Tissue Eng. 2006, 12, 75. [11] J. H. Cui, S. R. Park, K. Park, B. H. Choi, B.-h. Min, Tissue Eng.\n2007, 13, 351. [12] J. Gričar, M. Zupančič, K. Čufar, G. Koch, U. Schmitt, P. Oven,\nAnn. Bot. 2006, 97, 943.\n[13] A. Opitz, A. Falchier, C.-G. Yan, E. M. Yeagle, G. S. Linn, P. Megevand, A. Thielscher, M. P. Milham, A. D. Mehta, C. E. Schroeder, Sci. Rep. 2016, 6, 31236. [14] N. Grossman, D. Bono, N. Dedic, S. B. Kodandaramaiah, A. Rudenko, H.-J. Suk, A. M. Cassara, E. Neufeld, N. Kuster, L.-H. Tsai, Cell 2017, 169, 1029. [15] Y. Wang, L. Guo, Front. Neurosci. 2016, 10, 69. [16] L. He, G. Si, J. Huang, A. D. Samuel, N. Perrimon, Nature 2018,\n555, 103. [17] K. H. Vining, D. J. Mooney, Nat. Rev. Mol. Cell Biol. 2017, 18, 728. [18] J. L. Ruan, N. L. Tulloch, M. Saiget, S. L. Paige, M. V. Razumova,\nM. Regnier, K. C. Tung, G. Keller, L. Pabon, H. Reinecke, Stem Cells 2015, 33, 2148. [19] P. T. Yin, S. Shah, N. J. Pasquale, O. B. Garbuzenko, T. Minko, K.-B. Lee, Biomaterials 2016, 81, 46. [20] L. Chang, M. Howdyshell, W. C. Liao, C. L. Chiang, D. Gallego-Perez, Z. Yang, W. Lu, J. C. Byrd, N. Muthusamy, L. J. Lee, Small 2015, 11, 1818. [21] M. Yamaguchi, A. Ito, A. Ono, Y. Kawabe, M. Kamihira, ACS Synth. Biol. 2014, 3, 273. [22] P. K. Manikonda, P. Rajendra, D. Devendranath, B. Gunasekaran, R. Aradhya, R. Sashidhar, C. Subramanyam, Neurosci. Lett. 2007, 413, 145. [23] M. H. Cho, E. J. Lee, M. Son, J.-H. Lee, D. Yoo, J.-w. Kim, S. W. Park, J.-S. Shin, J. Cheon, Nat. Mater. 2012, 11, 1038. [24] J. H. Lee, E. S. Kim, M. H. Cho, M. Son, S. I. Yeon, J. S. Shin, J. Cheon, Angew. Chem., Int. Ed. 2010, 49, 5698. [25] J. Dobson, Nat. Nanotechnol. 2008, 3, 139. [26] A. Tay, D. Di Carlo, Nano Lett. 2017, 17, 886. [27] A. H. Lewis, J. Grandl, eLife 2015, 4, e12088. [28] Ç. Atak, Ö. Çelik, A. Olgun, S. Alikamanoğlu, A. Rzakoulieva,\nBiotechnol. Biotechnol. Equip. 2007, 21, 166. [29] Y. Zhu, Q. Yang, M. Yang, X. Zhan, F. Lan, J. He, Z. Gu, Y. Wu, ACS\nNano 2017, 11, 3690. [30] S. K. Boda, G. Thrivikraman, B. Basu, J. Mater. Chem. B 2015, 3, 3150. [31] P. Jiang, Y. Zhang, C. Zhu, W. Zhang, Z. Mao, C. Gao, Acta\nBiomater. 2016, 46, 141. [32] H. Xu, Z. P. Aguilar, L. Yang, M. Kuang, H. Duan, Y. Xiong, H. Wei,\nA. Wang, Biomaterials 2011, 32, 9758. [33] H.-M. Yun, S.-J. Ahn, K.-R. Park, M.-J. Kim, J.-J. Kim, G.-Z. Jin,\nH.-W. Kim, E.-C. Kim, Biomaterials 2016, 85, 88. [34] M. Antman-Passig, O. Shefi, Nano Lett. 2016, 16, 2567. [35] Y. Gao, J. Lim, S.-H. Teoh, C. Xu, Chem. Soc. Rev. 2015, 44, 6306. [36] H. Huang, S. Delikanli, H. Zeng, D. M. Ferkey, A. Pralle, Nat.\nNanotechnol. 2010, 5, 602. [37] J. Yao, J. Feng, J. Chen, Asian J Pharm. Sci. 2016, 11, 585. [38] E. Y. Salinas, J. C. Hu, K. Athanasiou, Tissue Eng., Part B 2018, 24,\n345. [39] S. R. MacEwan, A. Chilkoti, Nano Lett. 2012, 12, 3322. [40] J. D. Wells, C. Kao, E. D. Jansen, P. E. Konrad,\nA. Mahadevan-Jansen, J. Biomed. Opt. 2005, 10, 064003. [41] N. M. Idris, M. K. G. Jayakumar, A. Bansal, Y. Zhang, Chem. Soc.\nRev. 2015, 44, 1449. [42] J. Li, X. Zhen, Y. Lyu, Y. Jiang, J. Huang, K. Pu, ACS Nano 2018, 12,\n8520. [43] Y. Jiang, K. Pu, Acc. Chem. Res. 2018, 51, 1840. [44] J. Li, K. Pu, Chem. Soc. Rev. 2019, 48, 38. [45] Y. Wang, L. Feng, S. Wang, Adv. Funct. Mater. 2019, 29, 1806818. [46] J. Li, J. Rao, K. Pu, Biomaterials 2018, 155, 217. [47] H. Yang, J. Zhao, C. Wu, C. Ye, D. Zou, S. Wang, Chem. Eng. J.\n2018, 351, 548. [48] C. Wu, J. Zhao, F. Hu, Y. Zheng, H. Yang, S. Pan, S. Shi, X. Chen,\nS. Wang, Carbohydr. Polym. 2018, 180, 112. [49] J. Wei, J. Li, D. Sun, Q. Li, J. Ma, X. Chen, X. Zhu, N. Zheng,\nAdv. Funct. Mater. 2018, 28, 1706310.\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (16 of 18)\nAdv. Mater. 2019, 1901607\n[50] C. Qian, J. Yu, Y. Chen, Q. Hu, X. Xiao, W. Sun, C. Wang, P. Feng, Q. D. Shen, Z. Gu, Adv. Mater. 2016, 28, 3313. [51] H. Zhu, J. Li, X. Qi, P. Chen, K. Pu, Nano Lett. 2018, 18, 586. [52] R. Chai, C. Xing, D. Gao, H. Yuan, Y. Zhan, S. Wang, Adv.\nHealthcare Mater. 2018, 7, 1800674. [53] H. Dana, B. Mohar, Y. Sun, S. Narayan, A. Gordus, J. P. Hasseman,\nG. Tsegaye, G. T. Holt, A. Hu, D. Walpita, eLife 2016, 5, e12727. [54] E. Reichhart, A. Ingles-Prieto, A. M. Tichy, C. McKenzie,\nH. Janovjak, Angew. Chem., Int. Ed. 2016, 55, 6339. [55] J. Zhao, S. Lin, Y. Huang, J. Zhao, P. R. Chen, J. Am. Chem. Soc.\n2013, 135, 7410. [56] Y.-Y. He, J.-L. Huang, C. F. Chignell, J. Biol. Chem. 2004, 279,\n53867. [57] P. C. Ford, Coord. Chem. Rev. 2018, 376, 548. [58] Z. Chen, R. Thiramanas, M. Schwendy, C. Xie, S. H. Parekh,\nV. Mailänder, S. Wu, Small 2017, 13, 1700997. [59] J. Jang, T. G. Kim, B. S. Kim, S.-W. Kim, S.-M. Kwon, D.-W. Cho,\nActa Biomater. 2016, 33, 88. [60] G. Yang, X. Sun, J. Liu, L. Feng, Z. Liu, Adv. Funct. Mater. 2016, 26,\n4722. [61] X. Zhen, C. Xie, Y. Jiang, X. Ai, B. Xing, K. Pu, Nano Lett. 2018, 18,\n1498. [62] S. Mura, J. Nicolas, P. Couvreur, Nat. Mater. 2013, 12, 991. [63] M. K. Gnanasammandhan, N. M. Idris, A. Bansal, K. Huang,\nY. Zhang, Nat. Protoc. 2016, 11, 688. [64] J. S. Katz, J. A. Burdick, Macromol. Biosci. 2010, 10, 339. [65] A. L. Antaris, H. Chen, K. Cheng, Y. Sun, G. Hong, C. Qu,\nS. Diao, Z. Deng, X. Hu, B. Zhang, X. Zhang, O. K. Yaghi, Z. R. Alamparambil, X. Hong, Z. Cheng, H. Dai, Nat. Mater. 2016, 15, 235. [66] M. Karimi, P. S. Zangabad, S. Baghaee-Ravari, M. Ghazadeh, H. Mirshekari, M. R. Hamblin, J. Am. Chem. Soc. 2017, 139, 4584. [67] J. Li, J. Huang, Y. Lyu, J. Huang, Y. Jiang, C. Xie, K. Pu, J. Am. Chem. Soc. 2019, 141, 4073. [68] Q. Miao, K. Pu, Adv. Mater. 2018, 30, 1801778. [69] S. Wu, H. J. Butt, Adv. Mater. 2016, 28, 1208. [70] Z. Chen, S. He, H. J. Butt, S. Wu, Adv. Mater. 2015, 27, 2203. [71] T. Senthilkumar, L. Zhou, Q. Gu, L. Liu, F. Lv, S. Wang, Angew.\nChem., Int. Ed. 2018, 57, 13114. [72] J. Li, C. Xie, J. Huang, Y. Jiang, Q. Miao, K. Pu, Angew. Chem., Int.\nEd. 2018, 57, 3995. [73] M. Li, X. Yang, J. Ren, K. Qu, X. Qu, Adv. Mater. 2012, 24, 1722. [74] L. Lin, L. Liu, B. Zhao, R. Xie, W. Lin, H. Li, Y. Li, M. Shi,\nY.-G. Chen, T. A. Springer, X. Chen, Nat. Nanotechnol. 2015, 10, 465. [75] M. D. Blankschien, L. A. Pretzer, R. Huschka, N. J. Halas, R. Gonzalez, M. S. Wong, ACS Nano 2013, 7, 654. [76] B. Q. Spring, R. B. Sears, L. Z. Zheng, Z. Mai, R. Watanabe, M. E. Sherwood, D. A. Schoenfeld, B. W. Pogue, S. P. Pereira, E. Villa, Nat. Nanotechnol. 2016, 11, 378. [77] H. He, Y. Chen, Y. Li, Z. Song, Y. Zhong, R. Zhu, J. Cheng, L. Yin, Adv. Funct. Mater. 2018, 28, 1706710. [78] J. Lee, D. G. Udugamasooriya, H.-S. Lim, T. Kodadek, Nat. Chem. Biol. 2010, 6, 258. [79] A. T. Young, N. Cornwell, M. A. Daniele, Adv. Funct. Mater. 2018, 28, 1700239. [80] E. S. Boyden, F. Zhang, E. Bamberg, G. Nagel, K. Deisseroth, Nat. Neurosci. 2005, 8, 1263. [81] K. Huang, Q. Dou, X. J. Loh, RSC Adv. 2016, 6, 60896. [82] J. Y. Lin, P. M. Knutsen, A. Muller, D. Kleinfeld, R. Y. Tsien, Nat.\nNeurosci. 2013, 16, 1499. [83] H. Kim, Y. Park, S. Beack, S. Han, D. Jung, H. J. Cha, W. Kwon,\nS. K. Hahn, Adv. Sci. 2017, 4, 1700325. [84] N. Yu, L. Huang, Y. Zhou, T. Xue, Z. Chen, G. Han, Adv. Healthcare\nMater. 2019, 8, 1801132.\n[85] S. Hososhima, H. Yuasa, T. Ishizuka, M. R. Hoque, T. Yamashita, A. Yamanaka, E. Sugano, H. Tomita, H. Yawo, Sci. Rep. 2015, 5, 16533. [86] S. Shah, J.-J. Liu, N. Pasquale, J. Lai, H. McGowan, Z. P. Pang, K.-B. Lee, Nanoscale 2015, 7, 16571. [87] X. Wu, Y. Zhang, K. Takle, O. Bilsel, Z. Li, H. Lee, Z. Zhang, D. Li, W. Fan, C. Duan, E. M. Chan, C. Lois, Y. Xiang, G. Han, ACS Nano 2016, 10, 1060. [88] S. Chen, A. Z. Weitemier, X. Zeng, L. He, X. Wang, Y. Tao, A. J. Y. Huang, Y. Hashimotodani, M. Kano, H. Iwasaki, L. K. Parajuli, S. Okabe, D. B. L. Teh, A. H. All, I. Tsutsui-Kimura, K. F. Tanaka, X. Liu, T. J. McHugh, Science 2018, 359, 679. [89] X. Lin, Y. Wang, X. Chen, R. Yang, Z. Wang, J. Feng, H. Wang, K. W. Lai, J. He, F. Wang, P. Shi, Adv. Healthcare Mater. 2017, 6, 1700446. [90] J. V. Raimondo, L. Kay, T. J. Ellender, C. J. Akerman, Nat. Neurosci. 2012, 15, 1102. [91] X. Lin, X. Chen, W. Zhang, T. Sun, P. Fang, Q. Liao, X. Chen, J. He, M. Liu, F. Wang, P. Shi, Nano Lett. 2018, 18, 948. [92] J. L. Carvalho-de-Souza, J. S. Treger, B. Dang, S. B. Kent, D. R. Pepperberg, F. Bezanilla, Neuron 2015, 86, 207. [93] E. Miyako, J. Russier, M. Mauro, C. Cebrian, H. Yawo, C. Ménard-Moyon, J. A. Hutchison, M. Yudasaka, S. Iijima, L. De Cola, A. Bianco, Angew. Chem., Int. Ed. 2014, 53, 13121. [94] H. Nakatsuji, T. Numata, N. Morone, S. Kaneko, Y. Mori, H. Imahori, T. Murakami, Angew. Chem., Int. Ed. 2015, 54, 11725. [95] J. Yong, K. Needham, W. G. Brown, B. A. Nayagam, S. L. McArthur, A. Yu, P. R. Stoddart, Adv. Healthcare Mater. 2014, 3, 1862. [96] K. Eom, J. Kim, J. M. Choi, T. Kang, J. W. Chang, K. M. Byun, S. B. Jun, S. J. Kim, Small 2014, 10, 3853. [97] S. A. Chechetka, Y. Yu, X. Zhen, M. Pramanik, K. Pu, E. Miyako, Nat. Commun. 2017, 8, 15432. [98] Y. Lyu, C. Xie, S. A. Chechetka, E. Miyako, K. Pu, J. Am. Chem. Soc. 2016, 138, 9049. [99] S. Yoo, S. Hong, Y. Choi, J.-H. Park, Y. Nam, ACS Nano 2014, 8, 8040. [100] S. Yoo, R. Kim, J.-H. Park, Y. Nam, ACS Nano 2016, 10, 4274. [101] J. W. Lee, H. Jung, H. H. Cho, J. H. Lee, Y. Nam, Biomaterials 2018,\n153, 59. [102] E. J. Gomez, K. Gerhardt, J. Judd, J. J. Tabor, J. Suh, ACS Nano\n2016, 10, 225. [103] S. A. Stanley, J. E. Gagner, S. Damanpour, M. Yoshida,\nJ. S. Dordick, J. M. Friedman, Science 2012, 336, 604. [104] K. Zhang, B. Cui, Trends Biotechnol. 2015, 33, 92. [105] K. Watanabe, T. Ohtsuki, Prog. Mol. Biol. Transl. Sci. 2016,139, 101. [106] H. Ando, T. Furuta, R. Y. Tsien, H. Okamoto, Nat. Genet. 2001, 28, 317. [107] L. He, Y. Zhang, G. Ma, P. Tan, Z. Li, S. Zang, X. Wu, J. Jing,\nS. Fang, L. Zhou, Y. Wang, Y. Huang, P. G. Hogan, G. Han, Y. Zhou, eLife 2015, 4, e10024. [108] B. Zheng, H. Wang, H. Pan, C. Liang, W. Ji, L. Zhao, H. Chen, X. Gong, X. Wu, J. Chang, ACS Nano 2017, 11, 11898. [109] G. G. Genchi, A. Marino, A. Grillone, I. Pezzini, G. Ciofani, Adv. Healthcare Mater. 2017, 6, 1700002. [110] H.-w. Kim, K. Yang, W.-j. Jeong, S.-j. Choi, J. S. Lee, A.-N. Cho, G.-E. Chang, E. Cheong, S.-W. Cho, Y.-b. Lim, ACS Appl. Mater. Interfaces 2016, 8, 26470. [111] A. Marino, S. Arai, Y. Hou, A. Degl’Innocenti, V. Cappello, B. Mazzolai, Y.-T. Chang, V. Mattoli, M. Suzuki, G. Ciofani, ACS Nano 2017, 11, 2494. [112] Y. Lyu, D. Cui, H. Sun, Y. Miao, H. Duan, K. Pu, Angew. Chem., Int. Ed. 2017, 56, 9155. [113] E. Miyako, T. Deguchi, Y. Nakajima, M. Yudasaka, Y. Hagihara, M. Horie, M. Shichiri, Y. Higuchi, F. Yamashita, M. Hashida,\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (17 of 18)\nAdv. Mater. 2019, 1901607\nY. Shigeri, Y. Yoshida, S. Lijima, Proc. Natl. Acad. Sci. USA 2012, 109, 7523. [114] Y. Wang, S. Li, P. Zhang, H. Bai, L. Feng, F. Lv, L. Liu, S. Wang, Adv. Mater. 2018, 30, 1705418. [115] Y. Liu, G. Shu, X. Li, H. Chen, B. Zhang, H. Pan, T. Li, X. Gong, H. Wang, X. Wu, Y. Dou, J. Chang, Adv. Funct. Mater. 2018, 28, 1802026. [116] S. P. Sanchez-Rodriguez, J. P. Sauer, S. A. Stanley, X. Qian, A. Gottesdiener, J. M. Friedman, J. S. Dordick, Biotechnol. Bioeng. 2016, 113, 2228. [117] W. Gao, Y. Sun, M. Cai, Y. Zhao, W. Cao, Z. Liu, G. Cui, B. Tang, Nat. Commun. 2018, 9, 231. [118] A. Ambrosone, V. Marchesano, S. Carregal-Romero, D. Intartaglia, W. J. Parak, C. Tortiglione, ACS Nano 2016, 10, 4828. [119] R. A. Blidner, K. R. Svoboda, R. P. Hammer, W. T. Monroe, Mol. BioSyst. 2008, 4, 431. [120] Y. Matsushita-Ishiodori, T. Ohtsuki, Acc. Chem. Res. 2012, 45, 1039. [121] M. K. G. Jayakumar, N. M. Idris, Y. Zhang, Proc. Natl. Acad. Sci.\nUSA 2012, 109, 8483. [122] J. Li, C. W. T. Leung, D. S. H. Wong, J. Xu, R. Li, Y. Zhao,\nC. Y. Y. Yung, E. Zhao, B. Z. Tang, L. Bian, ACS Appl. Mater. Interfaces 2017, https://doi.org/10.1021/acsami.7b00845. [123] M. K. G. Jayakumar, A. Bansal, K. Huang, R. Yao, B. N. Li, Y. Zhang, ACS Nano 2014, 8, 4848. [124] M. K. G. Jayakumar, A. Bansal, B. N. Li, Y. Zhang, Nanomedicine 2015, 10, 1051. [125] S. Ranjan, M. K. G. Jayakumar, Y. Zhang, Nanomedicine 2015, 10, 1477. [126] W. Li, J. Wang, J. Ren, X. Qu, J. Am. Chem. Soc. 2014, 136, 2248. [127] C. J. Carling, F. Nourmohammadian, J. C. Boyer, N. R. Branda,\nAngew. Chem., Int. Ed. 2010, 49, 3782. [128] H. Kang, K. Zhang, D. S. H. Wong, F. Han, B. Li, L. Bian,\nBiomaterials 2018, 178, 681. [129] H. Kang, K. Zhang, Q. Pan, S. Lin, D. S. H. Wong, J. Li,\nW. Y. W. Lee, B. Yang, F. Han, G. Li, B. Li, L. Bian, Adv. Funct. Mater. 2018, 28, 1802642. [130] D. Ghezzi, M. R. Antognazza, R. Maccarone, S. Bellani, E. Lanzarini, N. Martino, M. Mete, G. Pertile, S. Bisti, G. Lanzani, Nat. Photonics 2013, 7, 400. [131] J. F. Maya-Vetencourt, D. Ghezzi, M. R. Antognazza, E. Colombo, M. Mete, P. Feyen, A. Desii, A. Buschiazzo, M. Di Paolo, S. Di Marco, Nat. Mater. 2017, 16, 681. [132] Y. Ma, J. Bao, Y. Zhang, Z. Li, X. Zhou, C. Wan, L. Huang, Y. Zhao, G. Han, T. Xue, Cell 2019, 177, 243. [133] T. S. Johnson, A. C. O’Neill, P. M. Motarjem, C. Amann, T. Nguyen, M. A. Randolph, J. M. Winograd, I. E. Kochevar, R. W. Redmond, J. Surg. Res. 2007, 143, 224. [134] S. J. Frost, D. Mawad, J. Hook, A. Lauto, Adv. Healthcare Mater. 2016, 5, 401. [135] S. Han, B. W. Hwang, E. Y. Jeon, D. Jung, G. H. Lee, D. H. Keum, K. S. Kim, S. H. Yun, H. J. Cha, S. K. Hahn, ACS Nano 2017, 11, 9979. [136] J. Li, H. Mao, N. Kawazoe, G. Chen, Biomater. Sci. 2017, 5, 173. [137] H. Koo, M. S. Huh, I.-C. Sun, S. H. Yuk, K. Choi, K. Kim,\nI. C. Kwon, Acc. Chem. Res. 2011, 44, 1018. [138] P. Cherukuri, E. S. Glazer, S. A. Curley, Adv. Drug Delivery Rev.\n2010, 62, 339. [139] R. R. Arvizo, S. Bhattacharyya, R. A. Kudgus, K. Giri,\nR. Bhattacharya, P. Mukherjee, Chem. Soc. Rev. 2012, 41, 2943. [140] S. J. Soenen, P. Rivera-Gil, J.-M. Montenegro, W. J. Parak,\nS. C. De Smedt, K. Braeckmans, Nano Today 2011, 6, 446. [141] N. Lee, S. H. Choi, T. Hyeon, Adv. Mater. 2013, 25, 2641. [142] E. B. Ehlerding, F. Chen, W. Cai, Adv. Sci. 2016, 3, 1500223. [143] S. Tang, C. Peng, J. Xu, B. Du, Q. Wang, R. D. Vinluan, III, M. Yu,\nM. J. Kim, J. Zheng, Angew. Chem., Int. Ed. 2016, 55, 16039.\n[144] G. Yang, L. Xu, Y. Chao, J. Xu, X. Sun, Y. Wu, R. Peng, Z. Liu, Nat. Commun. 2017, 8, 902. [145] G. Hong, J. C. Lee, J. T. Robinson, U. Raaz, L. Xie, N. F. Huang, J. P. Cooke, H. Dai, Nat. Med. 2012, 18, 1841. [146] J. Liu, M. Yu, C. Zhou, J. Zheng, Mater. Today 2013, 16, 477. [147] C. Xie, X. Zhen, Q. Miao, Y. Lyu, K. Pu, Adv. Mater. 2018, 30,\n1801331. [148] X. Zhang, B. Li, X. Luo, W. Zhao, J. Jiang, C. Zhang, M. Gao,\nX. Chen, Y. Dong, ACS Appl. Mater. Interfaces 2017, 9, 25481. [149] B. Xia, B. Wang, J. Shi, Y. Zhang, Q. Zhang, Z. Chen, J. Li, Acta\nBiomater. 2017, 51, 197. [150] A. Bianco, K. Kostarelos, M. Prato, Chem. Commun. 2011, 47,\n10182. [151] P. Huang, Y. Chen, H. Lin, L. Yu, L. Zhang, L. Wang, Y. Zhu, J. Shi,\nBiomaterials 2017, 125, 23. [152] Y. Chen, Q. Meng, M. Wu, S. Wang, P. Xu, H. Chen, Y. Li, L. Zhang,\nL. Wang, J. Shi, J. Am. Chem. Soc. 2014, 136, 16326. [153] L. Yu, Y. Chen, M. Wu, X. Cai, H. Yao, L. Zhang, H. Chen, J. Shi,\nJ. Am. Chem. Soc. 2016, 138, 9881. [154] Y. Lyu, J. Zeng, Y. Jiang, X. Zhen, T. Wang, S. Qiu, X. Lou, M. Gao,\nK. Pu, ACS Nano 2018, 12, 1801. [155] C. Yin, X. Zhen, Q. Fan, W. Huang, K. Pu, ACS Nano 2017, 11, 4174. [156] T. Lei, M. Guan, J. Liu, H.-C. Lin, R. Pfattner, L. Shaw,\nA. F. McGuire, T.-C. Huang, L. Shao, K.-T. Cheng, J. B.-H. Tok, Z. Bao, Proc. Natl. Acad. Sci. USA 2017, 114, 5107. [157] T. Repenko, A. Rix, S. Ludwanowski, D. Go, F. Kiessling, W. Lederle, A. J. Kuehne, Nat. Commun. 2017, 8, 470. [158] L. Cheng, C. Wang, L. Feng, K. Yang, Z. Liu, Chem. Rev. 2014, 114, 10869. [159] Y. Maruoka, T. Nagaya, K. Sato, F. Ogata, S. Okuyama, P. L. Choyke, H. Kobayashi, Mol. Pharmaceutics 2018, 15, 3634. [160] Y. Jiang, J. Li, X. Zhen, C. Xie, K. Pu, Adv. Mater. 2018, 30, 1705980. [161] Y. Jiang, P. K. Upputuri, C. Xie, Z. Zeng, A. Sharma, X. Zhen, J. Li, J. Huang, M. Pramanik, K. Pu, Adv. Mater. 2019, 31, 1808166. [162] L. Liu, S. Wang, B. Zhao, P. Pei, Y. Fan, X. Li, F. Zhang, Angew. Chem., Int. Ed. 2018, 57, 7518. [163] H. Lin, S. Gao, C. Dai, Y. Chen, J. Shi, J. Am. Chem. Soc. 2017, 139, 16235. [164] D. J. Garfield, N. J. Borys, S. M. Hamed, N. A. Torquato, C. A. Tajon, B. Tian, B. Shevitski, E. S. Barnard, Y. D. Suh, S. Aloni, Nat. Photonics 2018, 12, 402. [165] Y. Lyu, Y. Fang, Q. Miao, X. Zhen, D. Ding, K. Pu, ACS Nano 2016, 10, 4472. [166] J. Zhang, C. Yang, R. Zhang, R. Chen, Z. Zhang, W. Zhang, S. H. Peng, X. Chen, G. Liu, C. S. Hsu, Adv. Funct. Mater. 2017, 27, 1605094. [167] R. Zheng, S. Wang, Y. Tian, X. Jiang, D. Fu, S. Shen, W. Yang, ACS Appl. Mater. Interfaces 2015, 7, 15876. [168] S. Li, K. Chang, K. Sun, Y. Tang, N. Cui, Y. Wang, W. Qin, H. Xu, C. Wu, ACS Appl. Mater. Interfaces 2016, 8, 3624. [169] L. Huang, Z. Li, Y. Zhao, J. Yang, Y. Yang, A. I. Pendharkar, Y. Zhang, S. Kelmar, L. Chen, W. Wu, J. Zhao, G. Han, Adv. Mater. 2017, 29, 1604789. [170] W. Wu, D. Mao, F. Hu, S. Xu, C. Chen, C. J. Zhang, X. Cheng, Y. Yuan, D. Ding, D. Kong, Adv. Mater. 2017, 29, 1700548. [171] M. Zhang, Z. Cui, R. Song, B. Lv, Z. Tang, X. Meng, X. Chen, X. Zheng, J. Zhang, Z. Yao, W. Bu, Biomaterials 2018, 155, 135. [172] C. Wang, Q. Zhang, X. Wang, H. Chang, S. Zhang, Y. Tang, J. Xu, R. Qi, Y. Cheng, Angew. Chem., Int. Ed. 2017, 56, 6767. [173] Y. Lyu, J. Tian, J. Li, P. Chen, K. Pu, Angew. Chem., Int. Ed. 2018, 57, 13484.\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1901607 (18 of 18)\nAdv. Mater. 2019, 1901607\n[174] H.-D. Gao, P. Thanasekaran, C.-W. Chiang, J.-L. Hong, Y.-C. Liu, Y.-H. Chang, H.-M. Lee, ACS Nano 2015, 9, 7041. [175] Q. Pei, X. Hu, X. Zheng, S. Liu, Y. Li, X. Jing, Z. Xie, ACS Nano 2018, 12, 1630. [176] Y. Yuan, J. Liu, B. Liu, Angew. Chem., Int. Ed. 2014, 53, 7163. [177] L. Zhao, J. Peng, Q. Huang, C. Li, M. Chen, Y. Sun, Q. Lin, L. Zhu,\nF. Li, Adv. Funct. Mater. 2014, 24, 363.\n[178] L. Huang, Y. Zhao, H. Zhang, K. Huang, J. Yang, G. Han, Angew. Chem., Int. Ed. 2017, 56, 14400. [179] H. C. Huang, M. Pigula, Y. Fang, T. Hasan, Small 2018, 14, 1800236. [180] K. Sano, T. Nakajima, P. L. Choyke, H. Kobayashi, ACS Nano 2013, 7, 717. [181] Y. Mir, S. A. Elrington, T. Hasan, Nanomedicine 2013, 9, 1114."
    } ],
    "references" : [ {
      "title" : "Chem",
      "author" : [ "W. Li", "J. Wang", "J. Ren", "X. Qu", "J. Am" ],
      "venue" : "Soc. 2014, 136,",
      "citeRegEx" : "126",
      "shortCiteRegEx" : null,
      "year" : 2248
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "By taking advantage of the light-responsive property of photocleavable caging, controlled release of genic modulators in cells of interest has been demonstrated to allow remote regulation of gene expression and cellular functions.[126,127] In an interesting study, Bian and co-workers developed a UCNP-based carrier with photocleavable uncaging capability for NIR-light-mediated control of intracellular Ca2+ levels to regulate macrophage polarization.",
      "startOffset" : 230,
      "endOffset" : 239
    } ],
    "year" : 2019,
    "abstractText" : "DOI: 10.1002/adma.201901607 up magnetic equipment;[36] ultrasound has poor tissue targeting and may lead to metastatic disseminations owing to the enhanced vessel permeability;[37] heating and mechanical forces are poorly controllable both temporally and spatially;[38,39] and electrical stimulation is invasive and similarly has poor spatial selectivity.[40] Thereby, the limitations of these external stimuli partially hamper their biomedical applications. One emerging alternative to regulation of biological events is photoregulation, a process in which light is utilized as an external stimulus.[41] Because light has the intrinsic advantages of noninvasiveness, high spatiotemporal resolution, and easy controllability over intensity and wavelength,[42] photoregulation holds promise for an abundance of biomedical applications.[43–45] In addition to photothermal therapy (PTT)[46–48] and photodynamic therapy (PDT)[49–51] with the intention of killing disease cells, light-based applications include photothermal opening of ion channels,[52] photostimulation of lightsensitive proteins,[53–55] photoactivated uncaging of biomolecules,[56–58] photo-crosslinking of tissues,[59] and photocontrolled delivery of cargos.[60–62] However, photoregulation techniques often encounter certain predicaments that compromise their potential applications.[41,63] This mainly results from the widespread use of ultraviolet (UV) or visible light in photoregulation, because the majority of current light-sensitive moieties are only responsive to the light sources at these wavelengths.[63,64] UV and visible light have very shallow tissue penetration depth due to their high absorption and scattering in living tissues.[65] In addition, UV light with high energy per photon has a high probability to damage biomolecules (such as nucleic acids, proteins, and lipids), potentially leading to phototoxicity.[66] To address these issues, the replacement of UV and visible light with a near-infrared (NIR) light source (700–1000 nm) that has lower tissue absorption, less photon scattering, and deeper tissue penetration is highly desired to achieve photoregulation of different biological events.[67] Molecular transducers are essential for photoregulation of biological processes because there are few endogenous biomole cules with the ability to respond to NIR light.[68] In this regard, optical nanomaterials have shown their potential to be used as advanced nanotransducers to convert light into various forms of cues to trigger biological events or biomolecular activities. For example, upconversion nanoparticles (UCNPs) Photoregulation, which utilizes light to remotely control biological events, provides a precise way to decipher biology and innovate in medicine; however, its potential is limited by the shallow tissue penetration and/or phototoxicity of ultraviolet (UV)/visible light that are required to match the optical responses of endogenous photosensitive substances. Thereby, biologically friendly near-infrared (NIR) light with improved tissue penetration is desired for photoregulation. Since there are a few endogenous biomolecules absorbing or emitting light in the NIR region, the development of molecular transducers is essential to convert NIR light into the cues for regulation of biological events. In this regard, optical nanomaterials able to convert NIR light into UV/visible light, heat, or free radicals are suitable for this task. Here, the recent developments of optical nanotransducers for NIRlight-mediated photoregulation in medicine are summarized. The emerging applications, including photoregulation of neural activity, gene expression, and visual systems, as well as photochemical tissue bonding, are highlighted, along with the design principles of nanotransducers. Moreover, the current challenges and perspectives in this field are discussed. Nanotransducers",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}